Efficacy and Safety of Intra-gastric Balloon Placement in Dialyzed Patients Awaiting Kidney Transplantation
- PMID: 30474792
- DOI: 10.1007/s11695-018-3574-4
Efficacy and Safety of Intra-gastric Balloon Placement in Dialyzed Patients Awaiting Kidney Transplantation
Abstract
Background: The number of obese patients who are candidates for renal transplantation has considerably increased, but obesity can be a barrier to kidney transplantation. Weight loss is often difficult through diet alone. We studied the efficacy and tolerance of the intra-gastric balloon (IGB) procedure in obese patients who were undergoing dialysis and were candidates for a renal transplantation.
Patients and methods: Obese patients (BMI > 30 kg/m2) who were candidates for renal transplantation were prospectively included in the study between 2010 and 2012. The balloon was inserted and removed during a gastric endoscopy under general anesthesia. The treatment lasted 6 months. The end point was a decrease in BMI after 6 months. Body impedance spectrometry (BIS) and nutritional statute were evaluated initially and then after IGB removal.
Results: Seventeen patients (nine females and eight males) with a mean age of 53.4 years [19.4-69.4] were included. The decrease in body mass index (BMI) during the 6-month placement was 3 kg/m2 (from 37.7 to 34.4 kg/m2). The mean weight loss was 7 kg. The mean percentage of excess weight loss after 6 months was 20.2 (± 11.4). The tolerance was good without any complications. Eleven patients underwent kidney transplantation.
Conclusion: IGB in obese dialyzed patients who are candidates for renal transplantation is safe and effective. However, the amount of weight loss can vary.
Keywords: Awaiting kidney transplantation; Efficacy; Hemodialysis; Intra-gastric balloon; Obesity; Safety.
Similar articles
-
The Effect of Age, Gender, and Baseline BMI on Weight Loss Outcomes in Obese Patients Undergoing Intragastric Balloon Therapy.Obes Surg. 2019 Nov;29(11):3542-3546. doi: 10.1007/s11695-019-04023-y. Obes Surg. 2019. PMID: 31267474
-
Real-World Safety and Efficacy of Fluid-Filled Dual Intragastric Balloon for Weight Loss.Clin Gastroenterol Hepatol. 2018 Jul;16(7):1081-1088.e1. doi: 10.1016/j.cgh.2018.02.026. Epub 2018 Mar 2. Clin Gastroenterol Hepatol. 2018. PMID: 29481969
-
Intragastric Balloon for Overweight Patients.JSLS. 2016 Jan-Mar;20(1):e2015.00107. doi: 10.4293/JSLS.2015.00107. JSLS. 2016. PMID: 26955259 Free PMC article.
-
Intragastric Balloon Treatment for Obesity: Review of Recent Studies.Adv Ther. 2017 Aug;34(8):1859-1875. doi: 10.1007/s12325-017-0562-3. Epub 2017 Jul 13. Adv Ther. 2017. PMID: 28707286 Review.
-
Weight Loss in Advanced Chronic Kidney Disease: Should We Consider Individualised, Qualitative, ad Libitum Diets? A Narrative Review and Case Study.Nutrients. 2017 Oct 11;9(10):1109. doi: 10.3390/nu9101109. Nutrients. 2017. PMID: 29019954 Free PMC article. Review.
Cited by
-
Endoscopic intragastric balloon: a gimmick or a viable option for obesity?Ann Transl Med. 2020 Mar;8(Suppl 1):S8. doi: 10.21037/atm.2019.09.67. Ann Transl Med. 2020. PMID: 32309412 Free PMC article. Review.
-
[Intragastric balloon for weight reduction: rationale, benefits, risks and indications].Nan Fang Yi Ke Da Xue Xue Bao. 2020 Oct 30;40(10):1525-1529. doi: 10.12122/j.issn.1673-4254.2020.10.21. Nan Fang Yi Ke Da Xue Xue Bao. 2020. PMID: 33118505 Free PMC article. Chinese.
-
Exploring Adiposity and Chronic Kidney Disease: Clinical Implications, Management Strategies, Prognostic Considerations.Medicina (Kaunas). 2024 Oct 11;60(10):1668. doi: 10.3390/medicina60101668. Medicina (Kaunas). 2024. PMID: 39459455 Free PMC article. Review.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous